AmadeusValue’s Newsletter
Subscribe
Sign in
Home
Archive
About
Aclaris Therapeutics ($ACRS)
An intriguing busted biotech situation ($1.15 share price, $81.53m market cap, >$1.5m USD ADTV). Upside estimate of +27-58%, or assuming a six-month…
Feb 6
•
AmadeusValue
6
Share this post
Aclaris Therapeutics ($ACRS)
amadeusvalue.substack.com
Copy link
Facebook
Email
Note
Other
15
Comms Group (CCG AX)
An Australian nano-cap lollapalooza offering +170% to +250% returns over the next three years
Feb 25, 2022
•
AmadeusValue
9
Share this post
Comms Group (CCG AX)
amadeusvalue.substack.com
Copy link
Facebook
Email
Note
Other
7
My background, objectives and investment process
Inaugural post
Jun 11, 2021
•
AmadeusValue
8
Share this post
My background, objectives and investment process
amadeusvalue.substack.com
Copy link
Facebook
Email
Note
Other
3
Global opportunistic value investing in inefficient markets
Welcome to AmadeusValue’s Newsletter by me, AmadeusValue.
Jun 10, 2021
•
AmadeusValue
2
Share this post
Global opportunistic value investing in inefficient markets
amadeusvalue.substack.com
Copy link
Facebook
Email
Note
Other
AmadeusValue’s Newsletter
Global opportunistic value investing in inefficient markets
Subscribe
AmadeusValue’s Newsletter
Subscribe
About
Archive
Sitemap
Share this publication
AmadeusValue’s Newsletter
amadeusvalue.substack.com
Copy link
Facebook
Email
Note
Other
Share
Copy link
Facebook
Email
Note
Other
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
